Norbert W. Bischofberger
2017
In 2017, Norbert W. Bischofberger earned a total compensation of $6.1M as Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,443,050 |
|---|---|
| Option Awards | $1,850,084 |
| Salary | $1,080,692 |
| Stock Awards | $1,761,484 |
| Other | $10,000 |
| Total | $6,145,310 |
Bischofberger received $1.9M in option awards, accounting for 30% of the total pay in 2017.
Bischofberger also received $1.4M in non-equity incentive plan, $1.1M in salary, $1.8M in stock awards and $10K in other compensation.
Rankings
In 2017, Norbert W. Bischofberger's compensation ranked 1,422nd out of 14,666 executives tracked by ExecPay. In other words, Bischofberger earned more than 90.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,422 out of 14,666 | 90th |
Division Manufacturing | 486 out of 5,768 | 92nd |
Major group Chemicals And Allied Products | 127 out of 2,074 | 94th |
Industry group Drugs | 90 out of 1,730 | 95th |
Industry Biological Products, Except Diagnostic Substances | 18 out of 316 | 94th |
Source: SEC filing on March 26, 2018.
Bischofberger's colleagues
We found five more compensation records of executives who worked with Norbert W. Bischofberger at Gilead Sciences in 2017.